RNASE1 and neoplasm: However, potential limitations exist, such as the risk of immunogenicity or long-term accumulation of CdTe quantum dots in vivo, limited penetration within dense tumor microenvironments which may reduce efficacy in larger or hypoxic tumors, and variability in RNase A activity depending on intracellular conditions, which can affect reproducibility.